Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cogent Biosciences Inc (NQ: COGT )

9.390 +0.370 (+4.10%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 594,478
Open 8.750
Bid (Size) 8.900 (4)
Ask (Size) 9.690 (1)
Prev. Close 9.020
Today's Range 8.620 - 9.460
52wk Range 3.790 - 11.06
Shares Outstanding 45,819,266
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2022
Upgrades 
Via Benzinga
Cboe's Weekly Market Recap: June 6th To 10th
Exciting developments occurred on the Cboe Global Markets Inc. (BATS: CBOE) this week. 
Via Benzinga

Performance

YTD
+7.93%
+7.93%
1 Month
+111.96%
+111.96%
3 Month
+13.27%
+13.27%
6 Month
+7.93%
+7.93%
1 Year
+26.21%
+26.21%

More News

Read More
Mid-Afternoon Market Update: Dow Drops Over 600 Points; Fulcrum Therapeutics Shares Tumble
Via Benzinga
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
Via Benzinga
Exposures COVID-19
89 Biggest Movers From Friday
Via Benzinga
91 Biggest Movers From Friday
Via Benzinga
Cogent Biosciences (COGT) Stock Soars 90% on Positive Clinical Data
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Shares Of Cogent Biosciences Are Trading Higher
Via Benzinga
Mid-Day Market Update: Nasdaq Dips 400 Points; Cogent Biosciences Shares Jump
Via Benzinga
44 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Mid-Morning Market Update: Markets Open Lower; US Inflation Rate Accelerates to 8.6%
Via Benzinga
Bristol Myers Snaps Up Turning Point For $4.1 Billion In Cash — Is The Biotech Bear Dead?
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2021
Via Benzinga
60 Biggest Movers From Yesterday
Via Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
Via Benzinga
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
Via Benzinga
The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues
Via Benzinga
The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO
Via Benzinga
The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
Via Benzinga
Topics Product Recall
Exposures COVID-19 Legal Product Safety
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.